VanEck Australian Floating Rate ETF vs Novavax Inc — how do they compare? VanEck Australian Floating Rate ETF trades at $50.97, while Novavax Inc trades at $8.21 (market cap $1.39B). The key difference: VanEck Australian Floating Rate ETF is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| FLOT | NVAX | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $51.09 | $11.19 |
52-Week Low | $50.72 | $6.22 |
Market Cap | — | $1.39B |
Enterprise Value | — | $890.94M |
Trailing returns across standard periods
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →